Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis

Published:2014-07-21 Issue:2 Volume:78 Page:258-273
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Turner Richard M.¹²,Kwok Chun S.³,Chen-Turner Chen²,Maduakor Chinedu A.³,Singh Sonal⁴,Loke Yoon K.³

Affiliation:

1. Department of Molecular and Clinical Pharmacology; University of Liverpool; Liverpool UK

2. Royal Liverpool University Hospital; Liverpool UK

3. Norwich Medical School; University of East Anglia; Norwich UK

4. Johns Hopkins University School of Medicine; Baltimore MD USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12306/fullpdf

Reference62 articles.

1. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

2. Examining the safety of PPAR agonists - current trends and future prospects;Bortolini;Expert Opin Drug Saf,2013

3. European Medicines Agency Actos: European public assessment report - Product Information 2012 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000285/human_med_000624.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124

4. Assessment report for Actos, Glustin, Competact, Glubrava, Tandemact 2011 http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Assessment_Report_-_Variation/human/000285/WC500126656.pdf

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the molecular mechanism of Ling-Gui-Zhu-Gan decoction for the treatment of type 2 diabetes mellitus based on network pharmacology and molecular docking: A review;Medicine;2023-03-24

2. Diabetes and Cancer;The Diabetes Textbook;2023

3. The “Old” Oral Antidiabetics;The Diabetes Textbook;2023

4. Tailoring the Treatment of Type 2 Diabetes Mellitus to the Individual;Diabetes and Cardiovascular Disease;2023

5. Multinational Patterns of Second-line Anti-hyperglycemic Drug Initiation Across Cardiovascular Risk Groups: A Federated Pharmacoepidemiologic Evaluation in LEGEND-T2DM;2022-12-30